Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-14 6:41 pm Sale |
2024-12-31 | 13G | Recursion Pharmaceuticals, Inc. RXRX |
RA Capital Management, L.P. | 7,725,096 2.000% |
-7,659,519![]() (-49.79%) |
Filing History |
2025-02-14 11:23 am Purchase |
2024-12-31 | 13G | Recursion Pharmaceuticals, Inc. RXRX |
ARK Investment Management LLC | 32,346,397 8.470% |
9,270,345![]() (+40.17%) |
Filing History |
2025-02-12 09:32 am Sale |
2024-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
BAILLIE GIFFORD & CO | 24,864,058 6.500% |
-375,812![]() (-1.49%) |
Filing History |
2025-02-05 5:28 pm Purchase |
2024-12-31 | 13G | Recursion Pharmaceuticals, Inc. RXRX |
BLACKROCK INC BLK |
23,436,636 6.100% |
2,693,839![]() (+12.99%) |
Filing History |
2024-11-12 4:57 pm Unchanged |
2024-09-30 | 13G | Recursion Pharmaceuticals, Inc. RXRX |
The Vanguard Group | 24,272,798 8.820% |
0 (Unchanged) |
Filing History |
2024-11-12 10:34 am Sale |
2024-11-08 | 13G | Recursion Pharmaceuticals, Inc. RXRX |
FMR CORP | 8,363,529 3.040% |
-2,533,757![]() (-23.25%) |
Filing History |
2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Recursion Pharmaceuticals, Inc. RXRX |
BLACKROCK INC BLK |
20,742,797 7.500% |
0 (Unchanged) |
Filing History |
2024-11-04 4:16 pm Purchase |
2024-09-30 | 13G | Recursion Pharmaceuticals, Inc. RXRX |
Kinnevik AB (publ) | 11,905,668 4.300% |
1,500,000![]() (+14.42%) |
Filing History |
2024-11-04 1:27 pm Purchase |
2024-09-30 | 13G | Recursion Pharmaceuticals, Inc. RXRX |
The Vanguard Group | 24,272,798 8.820% |
8,607,588![]() (+54.95%) |
Filing History |
2024-11-04 09:46 am Purchase |
2024-09-30 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
BAILLIE GIFFORD & CO | 25,239,870 9.200% |
25,239,870![]() (New Position) |
Filing History |
2024-10-22 3:24 pm Purchase |
2024-09-30 | 13G | Recursion Pharmaceuticals, Inc. RXRX |
BLACKROCK INC BLK |
20,742,797 7.500% |
8,348,925![]() (+67.36%) |
Filing History |
2024-10-18 10:59 am Purchase |
2024-09-30 | 13G | Recursion Pharmaceuticals, Inc. RXRX |
STATE STREET CORP STT |
12,870,272 4.700% |
718,626![]() (+5.91%) |
Filing History |
2024-07-08 4:17 pm Purchase |
2024-06-28 | 13G | Recursion Pharmaceuticals, Inc. RXRX |
RA Capital Management, L.P. | 15,384,615 5.900% |
15,384,615![]() (New Position) |
Filing History |
2024-02-13 5:12 pm Purchase |
2023-12-29 | 13G | Recursion Pharmaceuticals, Inc. RXRX |
The Vanguard Group | 15,665,210 7.520% |
5,607,847![]() (+55.76%) |
Filing History |
2024-02-12 12:21 pm Purchase |
2024-01-31 | 13G | Recursion Pharmaceuticals, Inc. RXRX |
ARK Investment Management LLC | 23,076,052 11.080% |
2,421,765![]() (+11.73%) |
Filing History |
2024-02-09 09:49 am Purchase |
2024-02-08 | 13G | Recursion Pharmaceuticals, Inc. RXRX |
FMR CORP | 10,897,286 5.231% |
10,897,286![]() (New Position) |
Filing History |
2024-01-29 5:25 pm Purchase |
2023-12-31 | 13G | Recursion Pharmaceuticals, Inc. RXRX |
BLACKROCK INC BLK |
12,393,872 6.000% |
1,726,248![]() (+16.18%) |
Filing History |
2024-01-29 4:00 pm Purchase |
2023-12-31 | 13G | Recursion Pharmaceuticals, Inc. RXRX |
ARK Investment Management LLC | 20,654,287 9.920% |
20,654,287![]() (New Position) |
Filing History |
2024-01-26 10:49 am Sale |
2023-12-29 | 13G | Recursion Pharmaceuticals, Inc. RXRX |
BAILLIE GIFFORD & CO | 24,179,504 11.610% |
-641,346![]() (-2.58%) |
Filing History |
2024-01-24 10:13 am Purchase |
2023-12-31 | 13G | Recursion Pharmaceuticals, Inc. RXRX |
STATE STREET CORP STT |
12,151,646 5.830% |
12,151,646![]() (New Position) |
Filing History |